HighTide Therapeutics, Inc. (HKG:2511)
2.750
-0.130 (-4.51%)
Jun 23, 2025, 3:56 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.42 billion as of June 23, 2025. Its market cap has decreased by -47.62% in one year.
Market Cap
1.42B
Enterprise Value
976.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.75
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.42B, a decrease of -77.79%. That is a compound annual growth rate of -63.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 20, 2025 | 1.48B | 126.77% |
Dec 31, 2024 | 653.76M | -90.20% |
Dec 29, 2023 | 6.67B | 4.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines | 230.13B |
Hansoh Pharmaceutical Group Company | 166.48B |
Innovent Biologics | 128.33B |
JD Health International | 126.72B |
WuXi Biologics | 98.06B |
Sino Biopharmaceutical | 89.24B |
CSPC Pharmaceutical Group | 87.10B |
Akeso | 81.95B |